Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

Eastern Spanish experience with nivolumab in metastatic renal cell carcinoma.

José JM, Jose M, Silverio R, Federico V, Isabel C, Martin OA, Inmaculada B, Cristina C, Julia HC, Dolores TM, Jose G, Paola P, Nieves DP, Vicent A, Sara B, Sara M, Julián L, Manuel S, Del Carmen MM, Ángel CM, Vicente G.

Clin Transl Oncol. 2020 Feb 11. doi: 10.1007/s12094-020-02288-9. [Epub ahead of print]

PMID:
32048159
2.

Correction: Adherence and Satisfaction of Smartphone- and Smartwatch-Based Remote Active Testing and Passive Monitoring in People With Multiple Sclerosis: Nonrandomized Interventional Feasibility Study.

Midaglia L, Mulero P, Montalban X, Graves J, Hauser SL, Julian L, Baker M, Schadrack J, Gossens C, Scotland A, Lipsmeier F, van Beek J, Bernasconi C, Belachew S, Lindemann M.

J Med Internet Res. 2019 Oct 8;21(10):e16287. doi: 10.2196/16287.

3.

Onset of clinical and MRI efficacy of ocrelizumab in relapsing multiple sclerosis.

Barkhof F, Kappos L, Wolinsky JS, Li DKB, Bar-Or A, Hartung HP, Belachew S, Han J, Julian L, Sauter A, Napieralski J, Koendgen H, Hauser SL.

Neurology. 2019 Nov 5;93(19):e1778-e1786. doi: 10.1212/WNL.0000000000008189. Epub 2019 Sep 4.

4.

Adherence and Satisfaction of Smartphone- and Smartwatch-Based Remote Active Testing and Passive Monitoring in People With Multiple Sclerosis: Nonrandomized Interventional Feasibility Study.

Midaglia L, Mulero P, Montalban X, Graves J, Hauser SL, Julian L, Baker M, Schadrack J, Gossens C, Scotland A, Lipsmeier F, van Beek J, Bernasconi C, Belachew S, Lindemann M.

J Med Internet Res. 2019 Aug 30;21(8):e14863. doi: 10.2196/14863. Erratum in: J Med Internet Res. 2019 Oct 8;21(10):e16287.

5.

The pro-death role of Cited2 in stroke is regulated by E2F1/4 transcription factors.

Huang T, González YR, Qu D, Huang E, Safarpour F, Wang E, Joselin A, Im DS, Callaghan SM, Boonying W, Julian L, Dunwoodie SL, Slack RS, Park DS.

J Biol Chem. 2019 May 24;294(21):8617-8629. doi: 10.1074/jbc.RA119.007941. Epub 2019 Apr 9.

PMID:
30967472
6.

Ocrelizumab infusion experience in patients with relapsing and primary progressive multiple sclerosis: Results from the phase 3 randomized OPERA I, OPERA II, and ORATORIO studies.

Mayer L, Kappos L, Racke MK, Rammohan K, Traboulsee A, Hauser SL, Julian L, Köndgen H, Li C, Napieralski J, Zheng H, Wolinsky JS.

Mult Scler Relat Disord. 2019 May;30:236-243. doi: 10.1016/j.msard.2019.01.044. Epub 2019 Jan 28.

PMID:
30844611
7.

Review of Boundary Violations in Rhode Island, 2012-2018.

Melo B, Julian L, McDonald JV.

R I Med J (2013). 2019 Mar 1;102(2):36-38.

PMID:
30823699
8.

Rationally Designed 3D Hydrogels Model Invasive Lung Diseases Enabling High-Content Drug Screening.

Tam RY, Yockell-Lelièvre J, Smith LJ, Julian LM, Baker AEG, Choey C, Hasim MS, Dimitroulakos J, Stanford WL, Shoichet MS.

Adv Mater. 2019 Feb;31(7):e1806214. doi: 10.1002/adma.201806214. Epub 2018 Dec 27.

PMID:
30589121
9.

No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a.

Havrdová E, Arnold DL, Bar-Or A, Comi G, Hartung HP, Kappos L, Lublin F, Selmaj K, Traboulsee A, Belachew S, Bennett I, Buffels R, Garren H, Han J, Julian L, Napieralski J, Hauser SL, Giovannoni G.

Mult Scler J Exp Transl Clin. 2018 Mar 12;4(1):2055217318760642. doi: 10.1177/2055217318760642. eCollection 2018 Jan-Mar.

10.

Reprogramming patient-derived tumor cells generates model cell lines for tuberous sclerosis-associated lymphangioleiomyomatosis.

Julian LM, Stanford WL.

Oncoscience. 2017 Nov 2;4(11-12):170-172. doi: 10.18632/oncoscience.375. eCollection 2017 Nov. No abstract available.

11.

Engineering PTEN-L for Cell-Mediated Delivery.

Lavictoire SJ, Gont A, Julian LM, Stanford WL, Vlasschaert C, Gray DA, Jomaa D, Lorimer IAJ.

Mol Ther Methods Clin Dev. 2017 Nov 21;9:12-22. doi: 10.1016/j.omtm.2017.11.006. eCollection 2018 Jun 15.

12.

Human Pluripotent Stem Cell-Derived TSC2-Haploinsufficient Smooth Muscle Cells Recapitulate Features of Lymphangioleiomyomatosis.

Julian LM, Delaney SP, Wang Y, Goldberg AA, Doré C, Yockell-Lelièvre J, Tam RY, Giannikou K, McMurray F, Shoichet MS, Harper ME, Henske EP, Kwiatkowski DJ, Darling TN, Moss J, Kristof AS, Stanford WL.

Cancer Res. 2017 Oct 15;77(20):5491-5502. doi: 10.1158/0008-5472.CAN-17-0925. Epub 2017 Aug 22.

13.

Direct reprogramming with SOX factors: masters of cell fate.

Julian LM, McDonald AC, Stanford WL.

Curr Opin Genet Dev. 2017 Oct;46:24-36. doi: 10.1016/j.gde.2017.06.005. Epub 2017 Jul 4. Review.

14.

Examining the reliability and validity of the Clinical Assessment Interview for Negative Symptoms within the Management of Schizophrenia in Clinical Practice (MOSAIC) multisite national study.

Blanchard JJ, Bradshaw KR, Garcia CP, Nasrallah HA, Harvey PD, Casey D, Csoboth CT, Hudson JI, Julian L, Lentz E, Nuechterlein KH, Perkins DO, Skale TG, Snowden LR, Tandon R, Tek C, Velligan D, Vinogradov S, O'Gorman C.

Schizophr Res. 2017 Jul;185:137-143. doi: 10.1016/j.schres.2017.01.011. Epub 2017 Jan 11.

PMID:
28087270
15.

ROCK signaling promotes collagen remodeling to facilitate invasive pancreatic ductal adenocarcinoma tumor cell growth.

Rath N, Morton JP, Julian L, Helbig L, Kadir S, McGhee EJ, Anderson KI, Kalna G, Mullin M, Pinho AV, Rooman I, Samuel MS, Olson MF.

EMBO Mol Med. 2017 Feb;9(2):198-218. doi: 10.15252/emmm.201606743.

16.

Fatigue and depression predict quality of life in patients with early multiple sclerosis: a longitudinal study.

Nourbakhsh B, Julian L, Waubant E.

Eur J Neurol. 2016 Sep;23(9):1482-6. doi: 10.1111/ene.13102. Epub 2016 Jul 14.

PMID:
27416110
17.

One-year clinical experience of perampanel in Spain: a multicentre study of efficacy and tolerability.

Garamendi-Ruiz I, García-García ME, Bertol-Alegre V, Mauri-Llerda JÁ, García-Morales I, Garayoa-Irigoyen V, Agúndez-Sarasola M, De Toledo-Heras M, García-Morales V, García-Gomara MJ, Arcos-Sánchez C, Gago-Veiga A, Escalza-Cortina I, Rueda-Mena E, Muñoz-Fargas E, Santos-Lasaosa S, Oliván-Usieto JA, Julián LD, Gómez-Esteban JC, Marinas-Alejo A.

Epileptic Disord. 2016 Jun 1;18(2):173-80. doi: 10.1684/epd.2016.0824.

18.

Circular replication-associated protein encoding DNA viruses identified in the faecal matter of various animals in New Zealand.

Steel O, Kraberger S, Sikorski A, Young LM, Catchpole RJ, Stevens AJ, Ladley JJ, Coray DS, Stainton D, Dayaram A, Julian L, van Bysterveldt K, Varsani A.

Infect Genet Evol. 2016 Sep;43:151-64. doi: 10.1016/j.meegid.2016.05.008. Epub 2016 May 20.

PMID:
27211884
19.

Human pluripotent stem cells.

Carpenedo RL, Julian LM, Stanford WL.

Methods. 2016 May 15;101:1-3. doi: 10.1016/j.ymeth.2016.04.012. Epub 2016 Apr 19. No abstract available.

PMID:
27090006
20.

Formula G1: Cell cycle in the driver's seat of stem cell fate determination.

Julian LM, Carpenedo RL, Rothberg JL, Stanford WL.

Bioessays. 2016 Apr;38(4):325-32. doi: 10.1002/bies.201500187. Epub 2016 Feb 9. Review.

PMID:
26857166
21.

Longitudinal associations between MRI and cognitive changes in very early MS.

Nourbakhsh B, Nunan-Saah J, Maghzi AH, Julian LJ, Spain R, Jin C, Lazar A, Pelletier D, Waubant E.

Mult Scler Relat Disord. 2016 Jan;5:47-52. doi: 10.1016/j.msard.2015.10.010. Epub 2015 Oct 26.

PMID:
26856943
22.

Avian Polyomavirus Genome Sequences Recovered from Parrots in Captive Breeding Facilities in Poland.

Dayaram A, Piasecki T, Chrząstek K, White R, Julian L, van Bysterveldt K, Varsani A.

Genome Announc. 2015 Sep 24;3(5). pii: e00986-15. doi: 10.1128/genomeA.00986-15.

23.

The Management of Schizophrenia in Clinical Practice (MOSAIC) Registry: a focus on patients, caregivers, illness severity, functional status, disease burden and healthcare utilization.

Nasrallah HA, Harvey PD, Casey D, Csoboth CT, Hudson JI, Julian L, Lentz E, Nuechterlein KH, Perkins DO, Kotowsky N, Skale TG, Snowden LR, Tandon R, Tek C, Velligan D, Vinogradov S, O'Gorman C.

Schizophr Res. 2015 Aug;166(1-3):69-79. doi: 10.1016/j.schres.2015.04.031. Epub 2015 May 28.

PMID:
26027848
24.

Transcriptional control of stem cell fate by E2Fs and pocket proteins.

Julian LM, Blais A.

Front Genet. 2015 Apr 28;6:161. doi: 10.3389/fgene.2015.00161. eCollection 2015. Review.

25.

Tissue-specific targeting of cell fate regulatory genes by E2f factors.

Julian LM, Liu Y, Pakenham CA, Dugal-Tessier D, Ruzhynsky V, Bae S, Tsai SY, Leone G, Slack RS, Blais A.

Cell Death Differ. 2016 Apr;23(4):565-75. doi: 10.1038/cdd.2015.36. Epub 2015 Apr 24.

26.

Genome Sequences of Beak and Feather Disease Virus in Urban Rainbow Lorikeets (Trichoglossus haematodus).

Collings DA, Collings BG, Julian L, Kurenbach B, Varsani A.

Genome Announc. 2015 Apr 23;3(2). pii: e00283-15. doi: 10.1128/genomeA.00283-15.

27.

Magnetic resonance imaging correlates of clinical outcomes in early multiple sclerosis.

Maghzi AH, Revirajan N, Julian LJ, Spain R, Mowry EM, Liu S, Jin C, Green AJ, McCulloch CE, Pelletier D, Waubant E.

Mult Scler Relat Disord. 2014 Nov;3(6):720-7. doi: 10.1016/j.msard.2014.07.003. Epub 2014 Jul 23.

PMID:
25891551
28.

Treatment adherence and transitioning youth in pediatric multiple sclerosis.

Lulu S, Julian L, Shapiro E, Hudson K, Waubant E.

Mult Scler Relat Disord. 2014 Nov;3(6):689-95.

29.

Identification of an avian polyomavirus associated with Adélie penguins (Pygoscelis adeliae).

Varsani A, Porzig EL, Jennings S, Kraberger S, Farkas K, Julian L, Massaro M, Ballard G, Ainley DG.

J Gen Virol. 2015 Apr;96(Pt 4):851-857. doi: 10.1099/vir.0.000038. Epub 2014 Dec 23.

PMID:
25537375
30.

The neural crest lineage as a driver of disease heterogeneity in Tuberous Sclerosis Complex and Lymphangioleiomyomatosis.

Delaney SP, Julian LM, Stanford WL.

Front Cell Dev Biol. 2014 Nov 25;2:69. doi: 10.3389/fcell.2014.00069. eCollection 2014. Review.

31.

A randomized controlled phase II trial of riluzole in early multiple sclerosis.

Waubant E, Maghzi AH, Revirajan N, Spain R, Julian L, Mowry EM, Marcus J, Liu S, Jin C, Green A, McCulloch CE, Pelletier D.

Ann Clin Transl Neurol. 2014 May;1(5):340-7. doi: 10.1002/acn3.60. Epub 2014 Apr 14.

32.

Rho-associated coiled-coil containing kinases (ROCK): structure, regulation, and functions.

Julian L, Olson MF.

Small GTPases. 2014;5:e29846. doi: 10.4161/sgtp.29846. Epub 2014 Jul 10. Review.

33.

Clinical beak and feather disease virus infection in wild juvenile eastern rosellas of New Zealand; biosecurity implications for wildlife care facilities.

Jackson B, Harvey C, Galbraith J, Robertson M, Warren K, Holyoake C, Julian L, Varsani A.

N Z Vet J. 2014 Sep;62(5):297-301. doi: 10.1080/00480169.2014.909750. Epub 2014 Jun 11. Erratum in: N Z Vet J. 2014 Nov;62(6):363.

PMID:
24916448
34.

Diverse small circular single-stranded DNA viruses identified in a freshwater pond on the McMurdo Ice Shelf (Antarctica).

Zawar-Reza P, Argüello-Astorga GR, Kraberger S, Julian L, Stainton D, Broady PA, Varsani A.

Infect Genet Evol. 2014 Aug;26:132-8. doi: 10.1016/j.meegid.2014.05.018. Epub 2014 May 22.

PMID:
24859088
35.

A novel papillomavirus in Adélie penguin (Pygoscelis adeliae) faeces sampled at the Cape Crozier colony, Antarctica.

Varsani A, Kraberger S, Jennings S, Porzig EL, Julian L, Massaro M, Pollard A, Ballard G, Ainley DG.

J Gen Virol. 2014 Jun;95(Pt 6):1352-1365. doi: 10.1099/vir.0.064436-0. Epub 2014 Mar 31.

PMID:
24686913
36.

Pigeon circoviruses display patterns of recombination, genomic secondary structure and selection similar to those of beak and feather disease viruses.

Stenzel T, Piasecki T, Chrząstek K, Julian L, Muhire BM, Golden M, Martin DP, Varsani A.

J Gen Virol. 2014 Jun;95(Pt 6):1338-1351. doi: 10.1099/vir.0.063917-0. Epub 2014 Mar 17.

PMID:
24639400
37.

Blebs produced by actin-myosin contraction during apoptosis release damage-associated molecular pattern proteins before secondary necrosis occurs.

Wickman GR, Julian L, Mardilovich K, Schumacher S, Munro J, Rath N, Zander SA, Mleczak A, Sumpton D, Morrice N, Bienvenut WV, Olson MF.

Cell Death Differ. 2013 Oct;20(10):1293-305. doi: 10.1038/cdd.2013.69. Epub 2013 Jun 21.

38.

Rational design and binding mode duality of MDM2-p53 inhibitors.

Gonzalez-Lopez de Turiso F, Sun D, Rew Y, Bartberger MD, Beck HP, Canon J, Chen A, Chow D, Correll TL, Huang X, Julian LD, Kayser F, Lo MC, Long AM, McMinn D, Oliner JD, Osgood T, Powers JP, Saiki AY, Schneider S, Shaffer P, Xiao SH, Yakowec P, Yan X, Ye Q, Yu D, Zhao X, Zhou J, Medina JC, Olson SH.

J Med Chem. 2013 May 23;56(10):4053-70. doi: 10.1021/jm400293z. Epub 2013 May 6.

PMID:
23597064
39.

Opposing regulation of Sox2 by cell-cycle effectors E2f3a and E2f3b in neural stem cells.

Julian LM, Vandenbosch R, Pakenham CA, Andrusiak MG, Nguyen AP, McClellan KA, Svoboda DS, Lagace DC, Park DS, Leone G, Blais A, Slack RS.

Cell Stem Cell. 2013 Apr 4;12(4):440-52. doi: 10.1016/j.stem.2013.02.001. Epub 2013 Mar 14.

40.

Avihepadnavirus diversity in parrots is comparable to that found amongst all other avian species.

Piasecki T, Harkins GW, Chrząstek K, Julian L, Martin DP, Varsani A.

Virology. 2013 Apr 10;438(2):98-105. doi: 10.1016/j.virol.2013.01.009. Epub 2013 Feb 12.

41.

The role of social support in anxiety for persons with COPD.

Dinicola G, Julian L, Gregorich SE, Blanc PD, Katz PP.

J Psychosom Res. 2013 Feb;74(2):110-5. doi: 10.1016/j.jpsychores.2012.09.022. Epub 2012 Oct 17.

42.

Extensive recombination detected among beak and feather disease virus isolates from breeding facilities in Poland.

Julian L, Piasecki T, Chrząstek K, Walters M, Muhire B, Harkins GW, Martin DP, Varsani A.

J Gen Virol. 2013 May;94(Pt 5):1086-1095. doi: 10.1099/vir.0.050179-0. Epub 2013 Jan 16.

PMID:
23324468
43.

The relationship between cognitive function and physical function in rheumatoid arthritis.

Shin SY, Julian L, Katz P.

J Rheumatol. 2013 Mar;40(3):236-43. doi: 10.3899/jrheum.120871. Epub 2013 Jan 15.

44.

Cognitive impairment occurs in children and adolescents with multiple sclerosis: results from a United States network.

Julian L, Serafin D, Charvet L, Ackerson J, Benedict R, Braaten E, Brown T, O'Donnell E, Parrish J, Preston T, Zaccariello M, Belman A, Chitnis T, Gorman M, Ness J, Patterson M, Rodriguez M, Waubant E, Weinstock-Guttman B, Yeh A, Krupp LB; Network of Pediatric MS Centers of Excellence.

J Child Neurol. 2013 Jan;28(1):102-7. doi: 10.1177/0883073812464816. Epub 2012 Nov 15.

45.

Relationship between perceived cognitive dysfunction and objective neuropsychological performance in persons with rheumatoid arthritis.

Shin SY, Katz P, Julian L.

Arthritis Care Res (Hoboken). 2013 Mar;65(3):481-6. doi: 10.1002/acr.21814.

46.

Evidence of multiple introductions of beak and feather disease virus into the Pacific islands of Nouvelle-Caledonie (New Caledonia).

Julian L, Lorenzo A, Chenuet JP, Bonzon M, Marchal C, Vignon L, Collings DA, Walters M, Jackson B, Varsani A.

J Gen Virol. 2012 Nov;93(Pt 11):2466-2472. doi: 10.1099/vir.0.045575-0. Epub 2012 Aug 1.

PMID:
22855782
47.

The Rb/E2F pathway modulates neurogenesis through direct regulation of the Dlx1/Dlx2 bigene cluster.

Ghanem N, Andrusiak MG, Svoboda D, Al Lafi SM, Julian LM, McClellan KA, De Repentigny Y, Kothary R, Ekker M, Blais A, Park DS, Slack RS.

J Neurosci. 2012 Jun 13;32(24):8219-30. doi: 10.1523/JNEUROSCI.1344-12.2012.

48.

Molecular characterisation of beak and feather disease virus (BFDV) in New Zealand and its implications for managing an infectious disease.

Massaro M, Ortiz-Catedral L, Julian L, Galbraith JA, Kurenbach B, Kearvell J, Kemp J, van Hal J, Elkington S, Taylor G, Greene T, van de Wetering J, van de Wetering M, Pryde M, Dilks P, Heber S, Steeves TE, Walters M, Shaw S, Potter J, Farrant M, Brunton DH, Hauber M, Jackson B, Bell P, Moorhouse R, McInnes K, Varsani A.

Arch Virol. 2012 Sep;157(9):1651-63. doi: 10.1007/s00705-012-1336-5. Epub 2012 May 26.

PMID:
22638639
49.

Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A).

Julian LJ.

Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S467-72. doi: 10.1002/acr.20561. Review. No abstract available.

50.

Quality of care in systemic lupus erythematosus: application of quality measures to understand gaps in care.

Yazdany J, Trupin L, Tonner C, Dudley RA, Zell J, Panopalis P, Schmajuk G, Julian L, Katz P, Criswell LA, Yelin E.

J Gen Intern Med. 2012 Oct;27(10):1326-33. Epub 2012 May 17.

Supplemental Content

Loading ...
Support Center